R-HyperCVAD Alternating with High-dose MTX AraC/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of rituximab, cyclophosphamide, vincristine, doxorubicin and dexamethasone, administered on a hyperfractionated schedule, and alternating with rituximab, and high-dose methotrexate and cytarabine that can be used for the treatment of mantle cell lymphoma (MCL), AIDS-related B-cell lymphomas, Burkitt lymphoma, chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), diffuse large B-cell lymphoma (DLBCL), acute lymphoblastic leukemia (ALL), and T-cell lymphoma.

**Synonyms:** - R-HCVAD Plus Methotrexate/Cytarabine - R-Hyper-CVAD/R-MA - R-Hyper-CVAD/R-MA (rituximab-abbs) - R-Hyper-CVAD/R-MA (rituximab-arrx) - R-Hyper-CVAD/R-MA (rituximab-blit) - R-Hyper-CVAD/R-MA (rituximab-pvvr) - R-Hyper-CVAD/R-MA (rituximab-rite) - R-Hyper-CVAD/R-MA (rituximab-rixa) - R-Hyper-CVAD/R-MA (rituximab-rixi) - R-HyperCVAD Alternating with High-dose MTX AraC Regimen - R-HyperCVAD/HD MTX AraC Regimen - R-HyperCVAD/MTX/AraC - R-hyperCVAD Alternating with R-Methotrexate-Cytarabine - Rituximab Plus Hyper-CVAD Alternating with R-Methotrexate/Cytarabine - Rituximab Plus HyperCVAD Alternating with R-Methotrexate/Cytarabine - Rituximab Plus HyperCVAD Alternating with Rituximab Plus High-dose Cytarabine and Methotrexate - Rituximab Plus HyperCVAD Alternating with Rituximab-Methotrexate/Cytarabine - Rituximab-Hyperfractionated Cyclophosphamide-Vincristine-Adriamycin-Dexamethasone Alternating with Rituximab/Cytarabine/Methotrexate